問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol Number一項多中心、開放標示之第二期研究,以評估口服 OPC-34712作為精神分裂症成年患者單一治療之安全性和耐受性

2010-01-01 - 2010-12-31

Phase II

Terminated5

  • Trial Applicant

    IQVIA RDS Taiwan Ltd.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator 陳震宇 Division of Psychiatry

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 廖定烈 Division of Psychiatry

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator NAN-YING CHIU Division of Psychiatry

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 林式穀 Division of Psychiatry

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 陳正宗 Division of Psychiatry

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    20 participants

  • Global

    300 participants